Particle.news

Download on the App Store

Berkshire Hathaway in Talks to Buy OxyChem for About $10 Billion, Reports Say

A sale would accelerate Occidental’s effort to reduce debt built up through major deals, notably Anadarko plus CrownRock.

Overview

  • Multiple outlets report advanced negotiations with a potential announcement within days, though neither Berkshire nor Occidental has confirmed the talks.
  • If completed, the purchase would be Berkshire’s largest since the 2022 Alleghany deal, supported by the conglomerate’s roughly $344 billion cash pile.
  • Berkshire is already Occidental’s largest shareholder with an ownership stake of about 28% valued at more than $11 billion.
  • OxyChem operates roughly 23 plants producing chlor-alkali, PVC and other materials used in water treatment, battery recycling and construction, generating about $5 billion in revenue over the past year.
  • JPMorgan estimates value near $10 billion, implying roughly 7–8x forward EBITDA, and says proceeds could lower Occidental’s leverage by about one full turn at the cost of future cash flow from projects like Battleground/Deer Park.